Aurobindo Pharma gains over 7.5% on US FDA nod to chronic kidney drug News News / News 6 years ago 464 Views comments The US Food and Drug Administration (FDA), late on Tuesday, gave an approval to Sevelamer Tablets. These are used to treat patients with chronic kidne... Read more
News Job insecurity worries loom large as govt announces merger of 17 presses News / News - 6 years ago
Comments